Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
4(36%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
3
27%
Ph not_applicable
3
27%
Ph phase_3
2
18%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(5)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Recruiting3
Terminated1
unknown1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (37.5%)
Phase 32 (25.0%)
N/A3 (37.5%)

Trials by Status

completed327%
terminated19%
unknown19%
withdrawn19%
active_not_recruiting19%
not_yet_recruiting19%
recruiting327%

Recent Activity

4 active trials
Showing 5 of 11
recruitingphase_2

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888
recruitingnot_applicable

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

NCT06145581
completed

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

NCT04501913
recruitingphase_2

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

NCT06265285
completed

Remote Monitoring in Cancer Care: A Platform Study

NCT05018208
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06179888Phase 2

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Recruiting
NCT06145581Not Applicable

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

Recruiting
NCT04501913

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Completed
NCT06265285Phase 2

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Recruiting
NCT05018208

Remote Monitoring in Cancer Care: A Platform Study

Completed
NCT07200830Phase 3

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Not Yet Recruiting
NCT05038254Not Applicable

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Active Not Recruiting
NCT03834571Phase 2

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Withdrawn
NCT03895918Not Applicable

Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients

Completed
NCT03967119

Assessments of Dynamic Variables of Fluid Responsiveness to Predict Desufflation-induced Hypotension in Urologic Patients Undergoing Laparoscopic Surgery

Unknown
NCT00290082Phase 3

Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients

Terminated

All 11 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
11